Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |